Aquaculture 2025

March 6 - 10, 2025

New Orleans, Louisiana USA

Add To Calendar 09/03/2025 16:45:0009/03/2025 17:05:00America/ChicagoAquaculture 2025THE USE OF PROBIOTICS TO MITIGATE ATLANTIC SEA SCALLOP Placopecten magellanicus MORTALITY FOLLOWING CHALLENGE WITH PATHOGENIC VIBRIO SPECIESBalcony MThe World Aquaculture Societyjohnc@was.orgfalseDD/MM/YYYYanrl65yqlzh3g1q0dme13067

THE USE OF PROBIOTICS TO MITIGATE ATLANTIC SEA SCALLOP Placopecten magellanicus MORTALITY FOLLOWING CHALLENGE WITH PATHOGENIC VIBRIO SPECIES

Kyle Brennan*, Jennifer Perry, Brian Beal, Timothy Bowden

 

School of Food and Agriculture

University of Maine

Orono, ME 04469 USA

Kyle.d.brennan@maine.edu

 



 

The Atlantic sea scallop (Placopecten magellanicus) supports one of the most economically important fisheries in the northeastern United States. As the demand for sea scallop meat increases, aquaculture productions must supplement wild harvest efforts to reduce our dependence on importation. Scallop farmers rely on the acquisition of juvenile sea scallops, known as spat, to continue production, but wild spat collection is inconsistent and limited to a short season. Hatcheries in the state of Maine could reliably produce spat year-round, but struggle with mortality events, presumably induced by pathogenic Vibrio species. Probiotics have decreased mortality amongst infected bivalve larvae in other industries and could be implemented to decrease larval sea scallop mortality.

 

Seven probiotic bacteria were identified from literature in similar industries and cultured for use in sea scallop hatcheries. These bacteria were screened in vitro for potential probiotic effects on sea scallop larvae. Bacterial competition assays were used to examine the inhibition of a model pathogen, Vibrio pectenicida, by probiotic candidates. Forty-eight-hour challenge trials involving larval sea scallops and V. pectenicida (10⁵ CFU/mL) were also conducted to test the effectiveness of applied probiotics on challenged and non-challenged larvae. Two probiotic candidates displayed beneficial impacts to Atlantic sea scallop larvae. Alteromonas macleodii (10⁵ CFU/mL) increased survival amongst challenged larvae (RPS 46% ± 11) and Pseudoalteromonas espejiana (10⁴ CFU/mL) amongst non-challenged larvae (RPS 46%).

 

The effect of both promising probiotic treatments on larval sea scallops were tested at a hatchery scale with in vivo challenge trials. A. macleodii had a negative impact on larvae growth and survival. P. espejiana improved the rate of larval sea scallop growth and development during the late straight hinge to early pediveliger stage, where larvae mortality typically occurs. This study can improve hatchery protocols through the implementation of the probiotic P. espejiana. Further optimization of hatchery protocols in tandem with probiotic inoculation may prove critical to the success of Atlantic sea scallop hatcheries in Maine.